Elevated levels of MMP-9 and ICAM-1 as well as endothelial cell-specific molecule-1 (ESM-1) and claudin-5 have been observed in migraine patients supporting the involvement of BBB disruption during attacks [71–73]. This evidence concerns the gene ICAM1 and migraine disorder.